Microbicide Trials Network

MTN-003 (VOICE) News Releases

Microbicide Trials Network Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, a Major HIV Prevention Study in Women

Nov 25, 2011

Questions and Answers on Decision to Modify VOICE, Outcome of November 17 DSMB Review

Nov 25, 2011

Microbicide Trials Network Statement on Decision to Discontinue Use of Oral Tenofovir Tablets in VOICE, a Major HIV Prevention Study in Women

Sep 28, 2011

Questions and Answers on Decision to Modify VOICE, Outcome of September 16 DSMB Review

Sep 28, 2011

Questions and Answers about the CDC TDF2 Study and VOICE

Jul 14, 2011

VOICE Study will Continue as it Considers What Action to Take After Results of Two Trials

Jul 13, 2011

Questions and Answers about Partners PrEP and VOICE

Jul 13, 2011

HIV Prevention Trial Milestone: VOICE Study Completes Enrollment of 5,000 Women

Jun 6, 2011

Microbicide Trials Network Statement on the status of VOICE Study following announcement to close the FEM-PrEP trial

Apr 18, 2011

Trial shows ARVs can prevent HIV in men who have sex with men, making VOICE study in women more important than ever

Nov 23, 2010

Results of CAPRISA 004 a turning point for HIV prevention, say MTN researchers conducting VOICE

Jul 19, 2010

VOICE Study, a major HIV prevention trial for women, is launched in Zimbabwe

Sep 16, 2009

HIV prevention trial of ARV-based strategies to begin next month

Jul 20, 2009